← Back to patent-cliff list

CAS 2675-89-0

2-chloro-N,N-dimethylacetamide

Codes: FIMA-010, EVENA-006

Application context (from source-drug indications)

Essential hypertensionAmlodipine Besylate/Fimasartan PotassiumHypertensionAmlodipine Besylate/Fimasartan PotassiumHypertensionFimasartan Potassium TrihydrateEssential hypertensionFimasartan Potassium TrihydrateHypercholesterolaemiaFimasartan Potassium TrihydrateChronic renal impairmentFimasartan Potassium TrihydrateRenal impairmentFimasartan Potassium TrihydrateHepatic function declineFimasartan Potassium TrihydrateSchizophreniaEvenamide Hydrochloride精神疾病Evenamide Hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
Amlodipine Besylate/Fimasartan PotassiumTier C — Watch / trade-
Fimasartan Potassium TrihydrateTier C — Watch / trade-
Evenamide HydrochlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.